Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
for Pruritus
17 locations incl. La Jolla
Sponsor: Sanofi
Sex: All·Age: 18 - 90
Code: NCT05263206·Phase 3·Recruiting·Listed Mar 2022